How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Integrated Cancer Care Management Service Platform Market
- By Service Type: Patient Data Management, Treatment Planning and Coordination, Remote Patient Monitoring, Clinical Decision Support, Patient Engagement and Education
- By End User: Hospitals and Cancer Centers, Oncology Clinics, Diagnostic Laboratories, Research Institutions, Home Healthcare Providers
- By Cancer Type: Breast Cancer Management, Lung Cancer Management, Colorectal Cancer Management, Prostate Cancer Management, Hematologic Cancer Management
- By Technology Platform: Cloud-based Platforms, On-premise Solutions, Mobile Applications, AI-powered Analytics, Telemedicine Integration
- By Integration Capability: Electronic Health Record (EHR) Integration, Laboratory Information System (LIS) Integration, Pharmacy Management Integration, Radiology Information System (RIS) Integration, Wearable Device Integration
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Patient Data Management leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Integrated Cancer Care Management Service Platform Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
End User 5
Cancer Type 5
Technology Platform 5
Integration Capability 5
Companies profiled
Varian Medical Systems (a Siemens Healthineers company)
Elekta AB
Cerner Corporation (now part of Oracle)
Epic Systems Corporation
McKesson Corporation
Philips Healthcare
GE Healthcare
Siemens Healthineers
IBM Watson Health
Flatiron Health (a Roche subsidiary)
Allscripts Healthcare Solutions
Medidata Solutions (a Dassault Systèmes company)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Varian Medical Systems (a Siemens Healthineers company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Elekta AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Cerner Corporation (now part of Oracle)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Epic Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →McKesson Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →GE Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Siemens Healthineers
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →IBM Watson Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Flatiron Health (a Roche subsidiary)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Allscripts Healthcare Solutions
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Medidata Solutions (a Dassault Systèmes company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →MedeAnalytics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →OncoEMR (by Practice Fusion)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →CureMetrix
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,435M by 2033 · 5.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Patient Data Management34.5
- Treatment Planning and Coordination15.3
- Remote Patient Monitoring10.4
- Clinical Decision Support22.4
- Patient Engagement and Education17.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,148M → $1,924M · 6.7%
Europe$799.8M → $1,109M · 4.2%
Asia Pacific$730.2M → $1,156M · 5.9%
Latin America$452.1M → $628.5M · 4.2%
Middle East and Africa$347.7M → $574.4M · 6.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.692026
5.702027
5.722028
5.742029
5.742030
5.742031
5.772032
5.772033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Varian Medical Systems (a Siemens Healthineers company)15.5
- Elekta AB26.1
- Cerner Corporation (now part of Oracle)9.8
- Epic Systems Corporation5.6
- McKesson Corporation8.9
- Philips Healthcare6.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type26.3%
End User20.2%
Cancer Type14.2%
Technology Platform26.8%
Integration Capability12.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.7
- Europe20.6
- Asia Pacific21.4
- Latin America11.7
- Middle East and Africa10.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Varian Medical Systems (a Siemens Healthineers company) | 77 | 94 | 90 | 91 | 96 | 85 | 89 |
| Elekta AB | 88 | 70 | 88 | 86 | 81 | 70 | 81 |
| Cerner Corporation (now part of Oracle) | 84 | 71 | 88 | 82 | 77 | 82 | 81 |
| Epic Systems Corporation | 74 | 57 | 64 | 64 | 73 | 77 | 68 |
| McKesson Corporation | 61 | 60 | 69 | 59 | 63 | 58 | 62 |
| Philips Healthcare | 65 | 49 | 46 | 71 | 55 | 46 | 55 |
| GE Healthcare | 57 | 40 | 52 | 41 | 41 | 46 | 46 |
| Siemens Healthineers | 54 | 42 | 53 | 51 | 52 | 59 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Varian Medical Systems (a Siemens Healthineers company)
- Elekta AB
- Cerner Corporation (now part of Oracle)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Varian Medical Systems (a Siemens Healthineers company) | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Elekta AB | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Cerner Corporation (now part of Oracle) | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Epic Systems Corporation | ✓ | − | ◐ | ◐ | ✓ | ◐ |
| McKesson Corporation | − | ◐ | ◐ | − | − | − |
| Philips Healthcare | ◐ | − | ◐ | ✓ | − | − |
| GE Healthcare | − | − | ◐ | − | − | − |
| Siemens Healthineers | ◐ | − | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Varian Medical Systems (a Siemens Healthineers company)89
2Elekta AB81
3Cerner Corporation (now part of Oracle)81
4Epic Systems Corporation68
5McKesson Corporation62
6Philips Healthcare55
7Siemens Healthineers52
8GE Healthcare46
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Varian Medical Systems (a Siemens Healthineers company)Elekta ABCerner Corporation (now part of Oracle)
Challenger1
Strong scale, closing on the leaders.
Epic Systems Corporation
Contender1
Focused players with pockets of strength.
McKesson Corporation
Niche3
Specialists in a single segment or region.
Philips HealthcareGE HealthcareSiemens Healthineers
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Integrated Cancer Care Management Service Platform Market — a $347M beachhead inside a $4.78B market.
Beachhead (SOM)$347Mobtainable near-term
Serviceable (SAM)$1.95Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Patient Data Management
Best fit — highest urgency & budget in Service Type.
Economic buyer77 fit
Treatment Planning and Coordination
Strong fit — clear ROI and a fast path to value.
End user64 fit
Remote Patient Monitoring
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Cancer Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel26%
Digital / self-serve23%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Integrated Cancer Care Management Service Platform Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified22%
Evaluation15%
Closed-won5%
$13.7KCAC
$69KLTV
5.0:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Integrated Cancer Care Management Service Platform Market is a resilient opportunity — $6.62B by 2033, compounding at 5.4%.
TAM · 2025$4.36Btoday
TAM · 2033$6.62Bforecast
CAGR5.4%2027–2033
Cumulative$48.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.62BTotal addressable market
SAM$2.42BServiceable available market
SOM$515MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.4% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.62BLarge & growingTAM by 2033 at 5.4% CAGR
$2.42BServiceable nowreachable with today’s model
$515MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.16BBear3.5% CAGR
$6.62BBase5.4% CAGR
$8.47BBull7.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Integrated Cancer Care Management Service Platform Market — a $4.32B market by 2033. Plan: grow share from 7.5% to 12.0%.
Market size · 2033$4.32Btotal addressable
Market CAGR5.6%2027–2033
Target share12.0%from 7.5% today
Revenue ambition$518Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.5% | 12.0% | At risk |
| Revenue | $331M | $518M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 31.5% | 42.2% | At risk |
| Customer retention | 88.9% | 96.2% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $63M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Integrated Cancer Care Management Service Platform Market conversation — a $3.13B market you can size, segment and defend in minutes.
Market size · 2033$3.13Btotal opportunity
Growth3.5%CAGR to 2033
Addressable buyers1,074+accounts in scope
Typical ROI7.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.1×return on cost, year one
< 2 mopayback period
$76K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Varian Medical Systems (a Siemens Healthineers company)Elekta ABCerner Corporation (now part of Oracle)Epic Systems CorporationMcKesson CorporationPhilips HealthcareGE HealthcareSiemens Healthineers+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Integrated Cancer Care Management Service Platform Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Integrated Cancer Care Management Service Platform Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Rare Hemophilia Factors Market
Market size, share, segmentation and regional forecast.
$404M market · 2025 base year
View reportPoultry Diagnostics Market
Market size, share, segmentation and regional forecast.
$790M market · 2025 base year
View reportHealthcare Biometric Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportIntegrated Blood Bank Information System Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportCell Cycle Analysis Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportMale Hypogonadism Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportTuberculosis Therapeutics Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPodiatry Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportBreakthrough Therapy (BT) Designation Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportMicrobiology & Bacterial Culture for Industrial Testing Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportMolecular Biology Enzymes And Kits & Reagents Market
Market size, share, segmentation and regional forecast.
$378M market · 2025 base year
View reportSurgical Equipment/Instruments Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.